reported that Met mitigated HGHF-induced ferroptosis in NIT-1 cells by regulating the GPX4/ACSL4 axis, resulting in an antiferroptotic effect similar to that of RAS3 [89]
In the context of patients with cancer these factors can be altered either by the tumor itself or the treatment, for example the hepatic lesion produced by some drugs, even changing the lipid metabolism, affecting the endogenous production of PUFAs n-3 [21], this is important because as Valenzuela et al., the liver is the organ with the greatest capacity to synthesize PUFAs in mammals [22], hence supplementation could be a way to obtain them
It appears to assist normal metabolic function and thus may reverse the damage caused by oxygen deprivation, protecting tissues until blood flow is restored
GSH also conjugates electrophilic xenobiotics for elimination and has been linked to activation of the Nrf2/HO-1 cytoprotective pathway
If you want your health in good hands, heres the place to be